QUILT-2.001: ALT-803 in Patients With Advanced Pancreatic Cancer in Conjunction With Gemcitabine and Nab-Paclitaxel
Clinical trial NCT02559674 · COMPLETED
Trial details
- NCT number
- NCT02559674
- Sponsor
- Altor BioScience
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2018-02-21
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.